See All Slides - tctmd.com

Slides

Presentation TCT 2012

Step 6: Clinical Regulatory Pathways

Presenter: Semih Oktay

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

$Mobilized CD 34+ Cells for Refractory Angina$

Presentation TCT 2012

Mobilized CD 34+ Cells for Refractory Angina

Presenter: Thomas Povsic

October 22, 2012

Presentation TCT 2012

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Presenter: Anupam Bhambhani

October 22, 2012

Presentation TCT 2012

CCTRN: Second Cycle Studies

Presenter: Emerson Perin

October 22, 2012

Presentation TCT 2012

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Presenter: Michael Reardon

October 22, 2012

Presentation TCT 2012

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

Presenter: Zoltan Turi

October 22, 2012

Presentation TCT 2012

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

Presentation TCT 2012

Presentation

Presenter: Isaac George

October 22, 2012

Advertisement

Slides

Step 6: Clinical Regulatory Pathways

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Mobilized CD 34+ Cells for Refractory Angina

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

CCTRN: Second Cycle Studies

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Mitral Valve Disease Hemodynamics, Balloon Valvuloplasty and the Edge-to-Edge Approach (Including Related Guidelines)

Position 4. Patient Preference Matters: Use PCI with DES Early and Liberally in Most Patients!

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presentation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content